調査レポート | • レポートコード：GIR-2104Z07478 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、インクレチン製剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。インクレチン製剤の種類別市場規模（グルカゴン様ペプチド-1受容体（GLP-1）アゴニスト、ジペプチジルペプチダーゼ-4（DPP-4）阻害剤）、用途別市場規模（経口薬、注射薬）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・インクレチン製剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline、Johnson & Johnson、Merck & Co、AstraZeneca、Novartis、Eli Lilly and Company、Boehringer Ingelheim、Takeda Pharmaceutical Company、Sanofi ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：グルカゴン様ペプチド-1受容体（GLP-1）アゴニスト、ジペプチジルペプチダーゼ-4（DPP-4）阻害剤 ・用途別分析2016年-2026年：経口薬、注射薬 ・インクレチン製剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・インクレチン製剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・インクレチン製剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・インクレチン製剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・インクレチン製剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Incretin-Based Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Incretin-Based Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Incretin-Based Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Incretin-Based Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Glucagon-like peptide-1 receptor (GLP-1) agonists
Dipeptidyl Peptidase-4 (DPP-4) inhibitors
Market segment by Application can be divided into
Oral Drugs
Injectable Drugs
The key market players for global Incretin-Based Drugs market are listed below:
GlaxoSmithKline
Johnson & Johnson
Merck & Co
AstraZeneca
Novartis
Eli Lilly and Company
Boehringer Ingelheim
Takeda Pharmaceutical Company
Sanofi
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Incretin-Based Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Incretin-Based Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Glucagon-like peptide-1 receptor (GLP-1) agonists
1.2.3 Dipeptidyl Peptidase-4 (DPP-4) inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Incretin-Based Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oral Drugs
1.3.3 Injectable Drugs
1.4 Global Incretin-Based Drugs Market Size & Forecast
1.4.1 Global Incretin-Based Drugs Sales in Value (2016-2026))
1.4.2 Global Incretin-Based Drugs Sales in Volume (2016-2026)
1.4.3 Global Incretin-Based Drugs Price by Type (2016-2026) & (US$/Unit)
1.5 Global Incretin-Based Drugs Production Capacity Analysis
1.5.1 Global Incretin-Based Drugs Total Production Capacity (2016-2026)
1.5.2 Global Incretin-Based Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Incretin-Based Drugs Market Drivers
1.6.2 Incretin-Based Drugs Market Restraints
1.6.3 Incretin-Based Drugs Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Incretin-Based Drugs Product and Services
2.1.4 GlaxoSmithKline Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Incretin-Based Drugs Product and Services
2.2.4 Johnson & Johnson Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Merck & Co
2.3.1 Merck & Co Details
2.3.2 Merck & Co Major Business
2.3.3 Merck & Co Incretin-Based Drugs Product and Services
2.3.4 Merck & Co Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca Incretin-Based Drugs Product and Services
2.4.4 AstraZeneca Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Incretin-Based Drugs Product and Services
2.5.4 Novartis Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Eli Lilly and Company
2.6.1 Eli Lilly and Company Details
2.6.2 Eli Lilly and Company Major Business
2.6.3 Eli Lilly and Company Incretin-Based Drugs Product and Services
2.6.4 Eli Lilly and Company Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business
2.7.3 Boehringer Ingelheim Incretin-Based Drugs Product and Services
2.7.4 Boehringer Ingelheim Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Takeda Pharmaceutical Company
2.8.1 Takeda Pharmaceutical Company Details
2.8.2 Takeda Pharmaceutical Company Major Business
2.8.3 Takeda Pharmaceutical Company Incretin-Based Drugs Product and Services
2.8.4 Takeda Pharmaceutical Company Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Incretin-Based Drugs Product and Services
2.9.4 Sanofi Incretin-Based Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Incretin-Based Drugs Sales by Manufacturer
3.1 Global Incretin-Based Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Incretin-Based Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Incretin-Based Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Incretin-Based Drugs Manufacturer Market Share
3.4.2 Top 6 Incretin-Based Drugs Manufacturer Market Share
3.5 Global Incretin-Based Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Incretin-Based Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Incretin-Based Drugs Market Size by Region
4.1.1 Global Incretin-Based Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Incretin-Based Drugs Revenue by Region (2016-2026)
4.2 North America Incretin-Based Drugs Revenue (2016-2026)
4.3 Europe Incretin-Based Drugs Revenue (2016-2026)
4.4 Asia-Pacific Incretin-Based Drugs Revenue (2016-2026)
4.5 South America Incretin-Based Drugs Revenue (2016-2026)
4.6 Middle East and Africa Incretin-Based Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Incretin-Based Drugs Sales in Volume by Type (2016-2026)
5.2 Global Incretin-Based Drugs Revenue by Type (2016-2026)
5.3 Global Incretin-Based Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Incretin-Based Drugs Sales in Volume by Application (2016-2026)
6.2 Global Incretin-Based Drugs Revenue by Application (2016-2026)
6.3 Global Incretin-Based Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Incretin-Based Drugs Sales by Type (2016-2026)
7.2 North America Incretin-Based Drugs Sales by Application (2016-2026)
7.3 North America Incretin-Based Drugs Market Size by Country
7.3.1 North America Incretin-Based Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Incretin-Based Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Incretin-Based Drugs Sales by Type (2016-2026)
8.2 Europe Incretin-Based Drugs Sales by Application (2016-2026)
8.3 Europe Incretin-Based Drugs Market Size by Country
8.3.1 Europe Incretin-Based Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Incretin-Based Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Incretin-Based Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Incretin-Based Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Incretin-Based Drugs Market Size by Region
9.3.1 Asia-Pacific Incretin-Based Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Incretin-Based Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Incretin-Based Drugs Sales by Type (2016-2026)
10.2 South America Incretin-Based Drugs Sales by Application (2016-2026)
10.3 South America Incretin-Based Drugs Market Size by Country
10.3.1 South America Incretin-Based Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Incretin-Based Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Incretin-Based Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Incretin-Based Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Incretin-Based Drugs Market Size by Country
11.3.1 Middle East & Africa Incretin-Based Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Incretin-Based Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Incretin-Based Drugs Typical Distributors
12.3 Incretin-Based Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Incretin-Based Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Incretin-Based Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Incretin-Based Drugs Product and Services
Table 6. GlaxoSmithKline Incretin-Based Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Incretin-Based Drugs Product and Services
Table 10. Johnson & Johnson Incretin-Based Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 12. Merck & Co Major Business
Table 13. Merck & Co Incretin-Based Drugs Product and Services
Table 14. Merck & Co Incretin-Based Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 16. AstraZeneca Major Business
Table 17. AstraZeneca Incretin-Based Drugs Product and Services
Table 18. AstraZeneca Incretin-Based Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Major Business
Table 21. Novartis Incretin-Based Drugs Product and Services
Table 22. Novartis Incretin-Based Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly and Company Major Business
Table 25. Eli Lilly and Company Incretin-Based Drugs Product and Services
Table 26. Eli Lilly and Company Incretin-Based Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 28. Boehringer Ingelheim Major Business
Table 29. Boehringer Ingelheim Incretin-Based Drugs Product and Services
Table 30. Boehringer Ingelheim Incretin-Based Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table 32. Takeda Pharmaceutical Company Major Business
Table 33. Takeda Pharmaceutical Company Incretin-Based Drugs Product and Services
Table 34. Takeda Pharmaceutical Company Incretin-Based Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sanofi Basic Information, Manufacturing Base and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Incretin-Based Drugs Product and Services
Table 38. Sanofi Incretin-Based Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Incretin-Based Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Incretin-Based Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Incretin-Based Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Incretin-Based Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Incretin-Based Drugs Production Site of Key Manufacturer
Table 44. Global Incretin-Based Drugs Sales by Region (2016-2021e) & (K Units)
Table 45. Global Incretin-Based Drugs Sales by Region (2021-2026) & (K Units)
Table 46. Global Incretin-Based Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Incretin-Based Drugs Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Incretin-Based Drugs Sales by Type (2016-2021e) & (K Units)
Table 49. Global Incretin-Based Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Global Incretin-Based Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Incretin-Based Drugs Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Incretin-Based Drugs Price by Type (2016-2021e) & (US$/Unit)
Table 53. Global Incretin-Based Drugs Price by Type (2021-2026) & (US$/Unit)
Table 54. Global Incretin-Based Drugs Sales by Application (2016-2021e) & (K Units)
Table 55. Global Incretin-Based Drugs Sales by Application (2021-2026) & (K Units)
Table 56. Global Incretin-Based Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Incretin-Based Drugs Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Incretin-Based Drugs Price by Application (2016-2021e) & (US$/Unit)
Table 59. Global Incretin-Based Drugs Price by Application (2021-2026) & (US$/Unit)
Table 60. North America Incretin-Based Drugs Sales by Country (2016-2021e) & (K Units)
Table 61. North America Incretin-Based Drugs Sales by Country (2021-2026) & (K Units)
Table 62. North America Incretin-Based Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Incretin-Based Drugs Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Incretin-Based Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. North America Incretin-Based Drugs Sales by Type (2021-2026) & (K Units)
Table 66. North America Incretin-Based Drugs Sales by Application (2016-2021e) & (K Units)
Table 67. North America Incretin-Based Drugs Sales by Application (2021-2026) & (K Units)
Table 68. Europe Incretin-Based Drugs Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Incretin-Based Drugs Sales by Country (2021-2026) & (K Units)
Table 70. Europe Incretin-Based Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Incretin-Based Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Incretin-Based Drugs Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Incretin-Based Drugs Sales by Type (2021-2026) & (K Units)
Table 74. Europe Incretin-Based Drugs Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Incretin-Based Drugs Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Incretin-Based Drugs Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Incretin-Based Drugs Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Incretin-Based Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Incretin-Based Drugs Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Incretin-Based Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Incretin-Based Drugs Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Incretin-Based Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Incretin-Based Drugs Sales by Application (2021-2026) & (K Units)
Table 84. South America Incretin-Based Drugs Sales by Country (2016-2021e) & (K Units)
Table 85. South America Incretin-Based Drugs Sales by Country (2021-2026) & (K Units)
Table 86. South America Incretin-Based Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Incretin-Based Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Incretin-Based Drugs Sales by Type (2016-2021e) & (K Units)
Table 89. South America Incretin-Based Drugs Sales by Type (2021-2026) & (K Units)
Table 90. South America Incretin-Based Drugs Sales by Application (2016-2021e) & (K Units)
Table 91. South America Incretin-Based Drugs Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Incretin-Based Drugs Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Incretin-Based Drugs Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Incretin-Based Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Incretin-Based Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Incretin-Based Drugs Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Incretin-Based Drugs Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Incretin-Based Drugs Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Incretin-Based Drugs Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Incretin-Based Drugs Typical Distributors
Table 103. Incretin-Based Drugs Typical Customers
List of Figures
Figure 1. Incretin-Based Drugs Picture
Figure 2. Global Incretin-Based Drugs Sales Market Share by Type in 2020
Figure 3. Glucagon-like peptide-1 receptor (GLP-1) agonists
Figure 4. Dipeptidyl Peptidase-4 (DPP-4) inhibitors
Figure 5. Global Incretin-Based Drugs Sales Market Share by Application in 2020
Figure 6. Oral Drugs
Figure 7. Injectable Drugs
Figure 8. Global Incretin-Based Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Incretin-Based Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Incretin-Based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Incretin-Based Drugs Sales (2016-2026) & (K Units)
Figure 30. Global Incretin-Based Drugs Production Capacity (2016-2026) & (K Units)
Figure 31. Global Incretin-Based Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Incretin-Based Drugs Market Drivers
Figure 33. Incretin-Based Drugs Market Restraints
Figure 34. Incretin-Based Drugs Market Trends
Figure 35. Global Incretin-Based Drugs Sales Market Share by Manufacturer in 2020
Figure 36. Global Incretin-Based Drugs Revenue Market Share by Manufacturer in 2020
Figure 37. Incretin-Based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Incretin-Based Drugs Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Incretin-Based Drugs Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Incretin-Based Drugs Sales Market Share by Region (2016-2026)
Figure 41. Global Incretin-Based Drugs Revenue Market Share by Region (2016-2026)
Figure 42. North America Incretin-Based Drugs Revenue (2016-2026) & (USD Million)
Figure 43. Europe Incretin-Based Drugs Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Incretin-Based Drugs Revenue (2016-2026) & (USD Million)
Figure 45. South America Incretin-Based Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Incretin-Based Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Global Incretin-Based Drugs Sales Market Share by Type (2016-2026)
Figure 48. Global Incretin-Based Drugs Revenue Market Share by Type (2016-2026)
Figure 49. Global Incretin-Based Drugs Price by Type (2016-2026) & (US$/Unit)
Figure 50. Global Incretin-Based Drugs Sales Market Share by Application (2016-2026)
Figure 51. Global Incretin-Based Drugs Revenue Market Share by Application (2016-2026)
Figure 52. Global Incretin-Based Drugs Price by Application (2016-2026) & (US$/Unit)
Figure 53. North America Incretin-Based Drugs Sales Market Share by Country (2016-2026)
Figure 54. North America Incretin-Based Drugs Revenue Market Share by Country (2016-2026)
Figure 55. North America Incretin-Based Drugs Sales Market Share by Type (2016-2026)
Figure 56. North America Incretin-Based Drugs Sales Market Share by Application (2016-2026)
Figure 57. Europe Incretin-Based Drugs Sales Market Share by Country (2016-2026)
Figure 58. Europe Incretin-Based Drugs Revenue Market Share by Country (2016-2026)
Figure 59. Europe Incretin-Based Drugs Sales Market Share by Type (2016-2026)
Figure 60. Europe Incretin-Based Drugs Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Incretin-Based Drugs Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Incretin-Based Drugs Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Incretin-Based Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Incretin-Based Drugs Sales Market Share by Application (2016-2026)
Figure 65. South America Incretin-Based Drugs Sales Market Share by Country (2016-2026)
Figure 66. South America Incretin-Based Drugs Revenue Market Share by Country (2016-2026)
Figure 67. South America Incretin-Based Drugs Sales Market Share by Type (2016-2026)
Figure 68. South America Incretin-Based Drugs Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Incretin-Based Drugs Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Incretin-Based Drugs Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Incretin-Based Drugs Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Incretin-Based Drugs Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のヒトマイクロバイオーム治療薬・診断市場規模・現状・予測（2021年-2027年） The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness. Rising cases of ch…- 世界の遺伝子治療薬市場規模・現状・予測（2021年-2027年） Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery Market Analysis and Insights: Global Drugs B…
- 世界のスプレーベース吸入剤市場 2021：企業別、地域別、種類・用途別 The Inhalation Spray-Based Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界のペプチド治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Peptide Therapeutics Drugs Market The global Peptide Therapeutics Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …
- 世界のペプチド治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Peptide Therapeutics Drugs Market The global Peptide Therapeutics Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …